MedTechBridge - USA Life Science Commercial Viability Academy             View this email in your browser

Dear member of MedTech Bridge,

We are happy to invite you to a one-day US MedTech Commercial Viability Academy at DTU in Denmark.  

In this Academy, you will gain a better understanding of the unique complexities of the US market; the motivations of the numerous stakeholders involved in the decision-making process; and how to better position for US market success.

MedTech Bridge has invited US market experts from RQR Partners, who have lived and succeeded in the global life science industry, to facilitate the day. 

If you are not already a member of MedTech Bridge, you can sign-up here: 

Sign up for event

Program

4 April 2019

 

8:00 - 8:30 Coffee and networking

8:30 - 8:45 Introduction

The USA Healthcare spend is 100X larger than Denmark. How can I enter this market?

8:45 - 9:30 Healthcare is a choice not a right to the US patient
The US is a consumer driven Healthcare market with significant patient costs, which is influenced by profit driven mentality of insurance providers, hospitals and clinicians. 

9:30 - 10:15 Health Insurance Landscape
While 85% of healthcare is supported by the government in Denmark, less than 50% is supported by the USA government. Profit and loss are as much of a concern as care. Understanding motive and money flow is essential to penetration, utilization and adoption. 

10:15 - 10:30 Break

10:30 - 11:15 Market Access; Penetration, Utilization, Adoption
Be prepared for a long process with significant challenges. Learning who the stakeholders are and gaining access will accelerate sales. 

11:15 - 12:00 Strategic Pricing: By User and Point Point of Care
What is the value of the problem you are solving, and who pays for it?

12:00 - 13:00 - Lunch

13:00 - 13:20 Recap of Morning Session
Consumers, Payors, Decision Makers and Pricing

13:20 - 14:00 Liability Protections and Watch-outs
6 Billion Dollars spent annually on malpractice claims in the US. There are ni monetary caps on the claims and the 75% is allocated to attorneys fees and administration.

14:00 - 14:45 Team Composition
In the USA, it is best practice to have allies and relationships with specialists practicing in regulatory, clinical, KOLs, Reimbursement, Legal, Marketing, Sales and Corporate Partnerships. 

14:45 - 15:15 Summary
Case study review of European companies who have successfully entered the US market.

15:15 - 15:30 Question & Answer Session

The Workshop takes place at
DTU Business
Kollegiebakken 421C
2800 Lyngby
 

A limited number of seats available and members of MedTech Bridge get priority.

Program

4 April 2019

 

8:00 - 8:30 Coffee and networking

8:30 - 8:45 Introduction

The USA Healthcare spend is 100X larger than Denmark. How can I enter this market?

8:45 - 9:30 Healthcare is a choice not a right to the US patient
The US is a consumer driven Healthcare market with significant patient costs, which is influenced by profit driven mentality of insurance providers, hospitals and clinicians. 

9:30 - 10:15 Health Insurance Landscape
While 85% of healthcare is supported by the government in Denmark, less than 50% is supported by the USA government. Profit and loss are as much of a concern as care. Understanding motive and money flow is essential to penetration, utilization and adoption. 

10:15 - 10:30 Break

10:30 - 11:15 Market Access; Penetration, Utilization, Adoption
Be prepared for a long process with significant challenges. Learning who the stakeholders are and gaining access will accelerate sales. 

11:15 - 12:00 Strategic Pricing: By User and Point Point of Care
What is the value of the problem you are solving, and who pays for it?

12:00 - 13:00 - Lunch

13:00 - 13:20 Recap of Morning Session
Consumers, Payors, Decision Makers and Pricing

13:20 - 14:00 Liability Protections and Watch-outs
6 Billion Dollars spent annually on malpractice claims in the US. There are ni monetary caps on the claims and the 75% is allocated to attorneys fees and administration.

14:00 - 14:45 Team Composition
In the USA, it is best practice to have allies and relationships with specialists practicing in regulatory, clinical, KOLs, Reimbursement, Legal, Marketing, Sales and Corporate Partnerships. 

14:45 - 15:15 Summary
Case study review of European companies who have successfully entered the US market.

15:15 - 15:30 Question & Answer Session

The Workshop takes place at
DTU Business
Kollegiebakken 421C
2800 Lyngby
 

A limited number of seats available and members of MedTech Bridge get priority.

Sign up here

About
RQR Partners is a firm which specializes in guiding global life science and health care entrepreneurs towards identifying, evaluating, and validating their technology’s commercial viability potential from ideation to market entry in the United States.


Jim Sargent Founder & Managing partnerJim Sargent
Founder and Managing Partner / 20+ years of life science experience / Pfizer, Boston Scientific United States and Boston Scientific Asia


Jim was responsible for penetrating new countries and integrating acquired companies into the US market. During this time, Jim also served as the Chairman of the Medical Devices Committee for the Korean delegation of AMCHAM. From this cultural and commercial foundation, Jim formed RQR Partners, focused on developing and evaluating commercial strategy and investment decisions for new innovations and technologies from across the globe. Jim’s main focus is our corporate development in international markets. Working directly with our foreign government partners and their respective life science ecosystems, he identifies investment needs and opportunities for their startups as they assess commercial strategy for the United States.



Eric HalvorsonErik Halvorson
Managing Partner / 30 Years life experience / Boston Scientific, smith and Nephew, Olympus and Coloplast



Eric has mastered the dynamics of the global life science market place, and has a great appreciation for cultural nuances and norms. He started his career with Boston Scientific and was an inaugural member of the urology business unit. Having also lived in Europe during his 12 years at BSC, Eric experienced firsthand the differences in the healthcare markets. Later, Eric took on General Management roles at Olympus (Japanese company) and Coloplast (Danish company). During his 30 years, he built fast growing companies, turned around underperforming businesses. As an executive for the strategics, he led several successful acquisitions, with a keen eye toward the commercial viability and strategic fit. As a past and current board member for numerous Medical Device and Digital Health companies, along with Physician Specialty Societies, he brings to RQR Partners in-depth expertise in the field, real life operating experience, and years of customer facing interactions. Eric has a strong track record of building new businesses, and making strategic acquisitions. He has successfully executed and integrated acquisitions into strategics ranging from $10M to $1.9B in size.

Sign up for free MedTech Bridge membership here
Copyright © 2019 DTU Executive Business Education, All rights reserved.


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.